Insecticides India began nearly five decades ago as a distribution company, not a manufacturer - it understood what farmers needed before it ever made a product. That farmer-first instinct still drives the business: it invents, makes and sells crop-protection chemicals under the “Tractor” brand, a name that has been a beacon of trust for over 40 years. The recurring approach is to take the latest technology - often through Japanese partnerships - and put it within the reach of India’s small and marginal farmers, then lock in loyalty through a distribution network that now touches 7.5 million of them.
Business segments
Three engines, one farmer - branded formulations sold through a vast rural network, a technical-synthesis backbone that feeds those brands and other companies, and a biologicals platform that is still taking root.
1. Branded formulations: the farmer-facing engine
A portfolio of over 130 products sold under the “Tractor” umbrella brand through 8,500 distributors - this is where the company’s brand equity and farmer relationships live.
- The Tractor brand is the moat - launched in 1986 and acquired by IIL in 2003, it is described as one of the most loved brands among Indian farmers and the country’s largest-selling termiticide; it now stretches across five products.
- Premium products are displacing generics - a tier called “Maharatna” (43 products, 15 of them “Focus” stars expected to cross INR35 crores in their first or second year) commands gross margins of 30-35%, and these premium products now make up 58% of B2C sales, up from a smaller share as the company deliberately cuts old generic lines.
- Japanese partnerships supply the newest molecules - Nissan Chemical Corporation has delivered more than six products since 2012, including Pulsar (the #1 fungicide brand in India) and the patented insecticide Shinwa; Corteva has added four products under the partnership, including Granuvia, a granular insecticide that protects paddy for up to 60 days.
- Distribution works like rural FMCG - 69% of sales are brand sales, pushed through 8,500 distributors and 70,000 retailers, with a 1,200-strong crop-advisor team that generates demand before product is shipped, the reverse of industry practice.
- Farmer engagement is physical and digital - in a single year the company ran 26,000 farmer meetings and 10,000 crop demonstrations, while the IIL 360 App gives its field force real-time stock, order and farmer-visit tracking.
2. Technical synthesis: the cost-and-supply engine
Backward integration into active-ingredient manufacturing reduces dependence on Chinese imports and gives IIL a cost edge on its own formulations, while also supplying other agrochemical companies.
- 95% of revenue is made in-house - six formulation plants and two technical-synthesis plants, with a combined formulation capacity of 70,000 tonnes a year, mean the company is not a trader reselling someone else’s chemicals.
- Technicals are the raw-material backbone - the Dahej plant was built specifically to manufacture technical-grade active ingredients that IIL previously had to import, so it now makes key raw materials internally that it once sourced from other nations.
- Multi-purpose plants create flexibility - the technical plants run 20 different streams and can switch from a single gram to multi-tonne batches, letting IIL respond to demand shifts without dedicated single-product lines.
- B2B is a meaningful side stream - 22% of revenue comes from selling technical and formulation products to other companies, turning a cost-saving capability into a standalone revenue line.
- China risk is being engineered out - 65.58% of input materials by value are now sourced within India, and the company’s capex strategy explicitly targets manufacturing the technicals its formulations need, so geopolitical supply shocks hurt less.
3. Biologicals and Kaeros: the next-generation bets
A wholly owned biologicals subsidiary and a new agri-science platform called Kaeros are the company’s vehicles for the shift toward bio-pesticides, bio-stimulants and a fresh distribution channel.
- Biologicals are a 16-product line already in the field - introduced in 2014 and housed under IIL Biologicals Limited since 2022, the range includes Mycoraja (root-system fungi) and Surya Zinc (zinc-solubilising bacteria), and has treated over 42 lakh acres.
- Kaeros is a second sales channel with its own brand - acquired in November 2024 and positioned under the “Dr. Dada” identity, it has already launched over 25 products and is meant to build an independent distribution reach while improving supply-chain efficiency through direct imports.
- Both are small but structurally separate - giving each its own subsidiary or brand keeps the core Tractor franchise focused while letting the new ventures experiment with different farmer segments and product categories without cannibalising the main business.
R&D and molecule discovery
Four in-house R&D centres and a Japanese joint venture give IIL the ability to reverse-engineer off-patent molecules, invent new combinations, and - through the JV - pursue entirely new chemical entities.
- Four labs, four jobs - Synthesis R&D works on backward integration and process development; Formulation R&D creates new mixtures and cost-optimised products; Biological R&D develops bio-pesticides and nano-technology products; and the OAT JV hunts for new molecules.
- 27 patents and counting - the portfolio covers synergistic fungicidal and insecticidal combinations, including a Hexaconazole-Carbendazim mix sold as ‘SOFIA’ and a Diafenthiuron-Acetamiprid wettable powder.
- The OAT & IIL JV is the long-range bet - IIL holds a 20% stake in a dedicated discovery lab equipped with GC-MS, LC-MSMS and NMR instruments, staffed by scientists with 25-plus years of experience, aiming to invent new agrochemical molecules from scratch.
- Lab-to-plant is in-house - the R&D centres sit next to the factories, and the company can scale from lab bench to kilo lab to pilot plant to commercial production without handing off to a third party.
Group structure and partners
A promoter-led company with 72.16% insider ownership, three wholly owned subsidiaries (one already wound down), a 20% Japanese R&D joint venture, and deep non-equity ties with Nissan and Corteva that supply the newest molecules.
- Promoters hold 72.16% - following a buyback, the Aggarwal family controls nearly three-quarters of the equity, with the third generation (Mr. Sanskar Aggarwal) joining the board in May 2026.
- Wholly owned subsidiaries serve specific purposes - Kaeros Research Limited runs the new Dr. Dada platform; IIL Biologicals Limited houses the bio-pesticide and bio-fertiliser business; IIL Overseas DMCC (Dubai) was incorporated for trading but never commenced operations and was dissolved in September 2025.
- Nissan and Corteva are the product pipeline - Nissan has delivered more than six products under exclusive or co-exclusive marketing rights since 2012; Corteva has launched two and has two more imminent, together feeding IIL’s premium Maharatna shelf.
- OAT Agrio plays a dual role - beyond the 20% JV for new-molecule discovery, OAT also has a marketing tie-up that supplies products like Chaperone and Tadaaki directly to IIL’s distribution network.